This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2018 Aug 11;392(10146):476.

doi: 10.1016/S0140-6736(18)31741-0. Epub 2018 Aug 9.

Department of Error

No authors listed

PMID: 30129462
DOI: 10.1016/S0140-6736(18)31741-0

Published Erratum

Department of Error

No authors listed. Lancet. 2018.

. 2018 Aug 11;392(10146):476.

doi: 10.1016/S0140-6736(18)31741-0. Epub 2018 Aug 9.

PMID: 30129462
DOI: 10.1016/S0140-6736(18)31741-0

No abstract available

PubMed Disclaimer

Erratum for

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
Wallace DJ, Furie RA, Tanaka Y, Kalunian KC, Mosca M, Petri MA, Dörner T, Cardiel MH, Bruce IN, Gomez E, Carmack T, DeLozier AM, Janes JM, Linnik MD, de Bono S, Silk ME, Hoffman RW. Wallace DJ, et al. Lancet. 2018 Jul 21;392(10143):222-231. doi: 10.1016/S0140-6736(18)31363-1. Lancet. 2018. PMID: 30043749 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations